ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 2 September 2009
Endocrine-Related Cancer (2009) In press
DOI: 10.1677/ERC-09-0129
Copyright © 2009 by the Society for Endocrinology.
This Article
Right arrow Accepted manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Schaaf, C.
Right arrow Articles by Renner, U.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaaf, C.
Right arrow Articles by Renner, U.

RESEARCH

Curcumin acts anti-tumourigenic and hormone-suppressive in murine and human pituitary tumour cells in vitro and in vivo

Christian Schaaf, Bing Shan, Michael Buchfelder, Marco Losa, Jürgen Kreutzer, Walter Rachinger, Gunter Stalla, Tobias Schilling, Eduardo Arzt, Marcelo Perone and Ulrich Renner

C Schaaf, Neuroendocrinology, Max-Planck-Institute of Psychiatry, Munich, Germany
B Shan, Neuroendocrinology, Max-Planck-Institute of Psychiatry, Munich, Germany
M Buchfelder, Neurosurgical Clinic, University of Erlangen-Nuremburg, Erlangen, Germany
M Losa, Dept. of Neurosurgery, Istituto San Raffaele, Milano, Italy
J Kreutzer, Neurosurgical Clinic, Technical University of Munich, Munich, Germany
W Rachinger, Neurosurgical Clinic, University of Munich, Munich, Germany
G Stalla, Neuroendocrinology, Max-Planck-Institute of Psychiatry, Munich, Germany
T Schilling, Dept. of Internal Medicine, University of Heidelberg, Heidelberg, Germany
E Arzt, Departamento de Fisiología y Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina
M Perone, Departamento de Fisiología y Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina
U Renner, Neuroendocrinology, Max-Planck-Institute of Psychiatry, Munich, D-80804, Germany

Correspondence: Ulrich Renner, Email: renner{at}mpipsykl.mpg.de

Abstract

Curcumin (Diferuloylmethan) is the active ingredient of the spice plant Curcuma longa and has been shown to act anti-tumourigenic in different types of tumours. Therefore we have studied its effect in pituitary tumour cell lines and adenomas. Proliferation of lactosomatotroph GH3 and somatotroph MtT/S rat pituitary cells as well as of corticotroph AtT20 mouse pituitary cells was inhibited by curcumin in monolayer cell culture and in colony formation assay in soft agar. FACS analysis demonstrated curcumin-induced cell cycle arrest at G2/M. Analysis of cell cycle proteins by immunoblotting showed reduction of Cyclin D1, CDK 4 and no change in p27kip. FACS analysis with Annexin-V-FITC/7AAD-staining demonstrated curcumin-induced early apoptosis after 3, 6, 12 and 24 h treatment and nearly no necrosis. Induction of DNA fragmentation, reduction of Bcl-2 and enhancement of cleaved caspase 3 further confirmed induction of apoptosis by curcumin. Growth of GH3 tumours in athymic nude mice was suppressed by curcumin in vivo. In endocrine pituitary tumour cell lines, GH, ACTH and PRL production was inhibited by curcumin. Studies in 25 human pituitary adenoma cell cultures have confirmed the anti-tumourigenic and hormone-suppressive effects of curcumin. Altogether, the results described in this report pose to this natural compound as a good candidate for therapeutic use on pituitary tumours.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Society for Endocrinology.